Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03207724 | Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia(OnFX) | completed | Phase 1 | 16 | Andrew Hendifar, MDOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04196816 | Surgery for Pancreatic Cancer With Oligo-Metastasis(SPaM) | completed | — | 200 | University Hospital, MontpellierOTHER | 1 | Dec 29, 2020 |
| clinicaltrials |
| NCT01487785 | Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients | completed | Phase 1 | 18 | Novartis PharmaceuticalsINDUSTRY | 3 | Dec 19, 2020 | clinicaltrials |
| NCT01576666 | Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 19, 2020 | clinicaltrials |
| NCT02332863 | Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. | completed | N/A | 44 | University of Colorado, DenverOTHER | 1 | Dec 9, 2020 | clinicaltrials |
| NCT04064034 | ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer | completed | N/A | 60 | Mayo ClinicOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03291938 | IACS-010759 in Advanced Cancers | completed | Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT03790423 | 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT01397019 | Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours | completed | Phase 2 | 56 | Per PfeifferOTHER | 1 | Nov 2, 2020 | clinicaltrials |
| NCT03180437 | Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 62 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Nov 2, 2020 | clinicaltrials |
| NCT00026104 | Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer | completed | Phase 2 | 154 | National Cancer Institute (NCI)NIH | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00114179 | Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 82 | National Cancer Institute (NCI)NIH | 1 | Oct 30, 2020 | clinicaltrials |
| NCT02459652 | Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer | completed | Phase 2 | 57 | Japan Adjuvant Study Group of Pancreatic CancerOTHER | 1 | Oct 27, 2020 | clinicaltrials |
| NCT02340728 | Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies | completed | Phase 3 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT02555813 | Treatment of Pancreatic Cancer With Abraxane | completed | — | 317 | CelgeneINDUSTRY | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02704143 | Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer | completed | N/A | 63 | Changhai HospitalOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer(Sequoia) | completed | Phase 3 | 567 | Eli Lilly and CompanyINDUSTRY | 13 | Oct 19, 2020 | clinicaltrials |
| NCT02045602 | Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | Theriva Biologics SLINDUSTRY | 1 | Oct 8, 2020 | clinicaltrials |
| NCT02101580 | Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 1 | 21 | Polaris GroupINDUSTRY | 1 | Oct 1, 2020 | clinicaltrials |
| NCT03962478 | Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction(HIFU) | completed | N/A | 92 | Xuzhou Central HospitalOTHER | 1 | Sep 30, 2020 | clinicaltrials |
| NCT01385956 | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT02289898 | Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma(YOSEMITE) | completed | Phase 2 | 207 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 6 | Sep 28, 2020 | clinicaltrials |
| NCT04560270 | CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer | completed | N/A | 69 | Poitiers University HospitalOTHER | 0 | Sep 23, 2020 | clinicaltrials |
| NCT03794128 | A Study of Personalized Neoantigen Cancer Vaccines | completed | — | 93 | Gritstone bio, Inc.INDUSTRY | 1 | Sep 11, 2020 | clinicaltrials |
| NCT01189929 | A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 1 | 57 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 3 | Sep 9, 2020 | clinicaltrials |
| NCT02005315 | A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer | completed | Phase 1 | 30 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT02050178 | Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer | completed | Phase 1 | 26 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT00769483 | MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 81 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT02790944 | Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer | completed | — | 300 | Ambry GeneticsINDUSTRY | 1 | Aug 25, 2020 | clinicaltrials |
| NCT02400398 | Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients(PanCax) | completed | — | 30 | Andrew Hendifar, MDOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | completed | Phase 2 | 34 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT02983500 | Patient Reported Outcomes Registry in Patient With Cancer Cachexia(PROXie) | completed | — | 253 | iOMEDICO AGINDUSTRY | 1 | Aug 7, 2020 | clinicaltrials |
| NCT00745381 | A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors | completed | — | 238 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | completed | Phase 1 | 39 | Massachusetts General HospitalOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy(PanCOVID) | completed | — | 730 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT01222689 | Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2020 | clinicaltrials |
| NCT02092948 | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer | completed | Phase 1 | 8 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT01839487 | PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | completed | Phase 2 | 279 | Halozyme TherapeuticsINDUSTRY | 1 | Jul 20, 2020 | clinicaltrials |
| NCT01908478 | Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer(VelGemRad) | completed | Phase 1 | 34 | Cedars-Sinai Medical CenterOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT03411200 | Patient Activation Through Counseling, Exercise and Mobilization(PACE-Mobil) | completed | N/A | 99 | Herlev and Gentofte HospitalOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT03415126 | A Study of ASN007 in Patients With Advanced Solid Tumors | completed | Phase 1 | 49 | Asana BioSciencesINDUSTRY | 1 | Jul 9, 2020 | clinicaltrials |
| NCT03168139 | Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer(Keynote-559) | completed | Phase 1 / Phase 2 | 20 | TME Pharma AGINDUSTRY | 1 | Jul 8, 2020 | clinicaltrials |
| NCT04385147 | Advanced Endoscopy During COVID-19 | completed | — | 670 | Al-Azhar UniversityOTHER | 5 | Jul 8, 2020 | clinicaltrials |
| NCT02841436 | A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer | completed | N/A | 7 | National Taiwan University HospitalOTHER | 0 | Jul 7, 2020 | clinicaltrials |
| NCT02153450 | Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer | completed | Early Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT00313560 | ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) | completed | Phase 2 | 48 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01803282 | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors | completed | Phase 1 | 236 | Gilead SciencesINDUSTRY | 1 | Jun 2, 2020 | clinicaltrials |
| NCT03914950 | TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer(TOF-P) | completed | N/A | 174 | Medical University of GrazOTHER | 0 | May 29, 2020 | clinicaltrials |
| NCT00255827 | Vaccine Treatment for Surgically Resected Pancreatic Cancer | completed | Phase 1 / Phase 2 | 7 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT00569387 | Vaccine Study for Surgically Resected Pancreatic Cancer | completed | Phase 2 | 73 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Dec 30, 2020source: clinicaltrials